Avenue Biosciences Overview
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$8.2M
- Investors
-
8
Avenue Biosciences General Information
Description
Developer of a protein engineering platform designed to accelerate the discovery and manufacturing of therapeutic biologics. The company offers high-throughput engineering of natural and synthetic signal peptides, synthetic biology capabilities, and therapeutic protein optimization technologies, enabling biotechnology and pharmaceutical companies to improve protein production efficiency and biologic quality during drug development.
Contact Information
Website
www.avenuebiosciences.comCorporate Office
- Viikinkaari 1A
- 00790 Helsinki
- Finland
Corporate Office
- Viikinkaari 1A
- 00790 Helsinki
- Finland
Avenue Biosciences Timeline
Avenue Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 12-Jan-2026 | $8.2M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 10-Jun-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 05-Jul-2024 | Completed | Product In Beta Test | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2023 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Avenue Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Avenue Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Avenue Biosciences Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Balnord | Venture Capital | Minority | ||
| Inventure | Venture Capital | Minority | ||
| Tesi | Limited Partner | Minority | ||
| Voima Ventures | Venture Capital | Minority | ||
| BioTools Innovator | Accelerator/Incubator |
Avenue Biosciences FAQs
-
Where is Avenue Biosciences headquartered?
Avenue Biosciences is headquartered in Helsinki, Finland.
-
What is the size of Avenue Biosciences?
Avenue Biosciences has 12 total employees.
-
What industry is Avenue Biosciences in?
Avenue Biosciences’s primary industry is Biotechnology.
-
Is Avenue Biosciences a private or public company?
Avenue Biosciences is a Private company.
-
What is Avenue Biosciences’s current revenue?
The current revenue for Avenue Biosciences is .
-
How much funding has Avenue Biosciences raised over time?
Avenue Biosciences has raised $8.7M.
-
Who are Avenue Biosciences’s investors?
Balnord, Inventure, Tesi, Voima Ventures, and BioTools Innovator are 5 of 8 investors who have invested in Avenue Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
